From the Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland (V.M., T.S., G.C., M.S., K.H., R.M., M.E., H.A.); Department of Radiological, Oncological, and Anatomopathological Sciences, Sapienza University of Rome, Rome, Italy (G.C.); Siemens Healthcare GmbH, Computed Tomography, Forchheim, Germany (T.A., B.S., T.F.); and Institute of Radiology, Spitäler fmi AG, Spital Interlaken, Unterseen, Switzerland (M.E.).

Received for publication March 14, 2023; and accepted for publication, after revision, April 6, 2023.

Conflicts of interest and sources of funding: none declared.

Disclosures: H.A. received institutional grants from Bayer, Guerbet, and Siemens, and is part of speaker's bureau of Siemens. R.M. received institutional grants from Bayer, and is part of the speaker's bureau of Siemens and Bayer. M.E. is part of the speaker's bureau of Siemens. T.A., B.S., and T.F. are employees of Siemens Healthcare GmbH.

V.M. and T.S. contributed equally as first authors.

Correspondence to: Hatem Alkadhi, MD, MPH, EBCR, FESER, Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland. E-mail: [email protected]; Victor Mergen, MD, Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland. E-mail: [email protected]; Thomas Sartoretti, MD, Institute of Diagnostic and Interventional Radiology, University Hospital Zurich, Raemistr. 100, CH-8091 Zurich, Switzerland. E-mail: [email protected].